[1]
ALKHAFAJI, G.A. and JANABI, A.M. 2025. GIP/GLP-1 DUAL AGONIST TIRZEPATIDE AMELIORATES RENAL ISCHEMIA/REPERFUSION DAMAGE IN RATS. International Journal of Applied Pharmaceutics. 17, 2 (Mar. 2025), 165–173. DOI:https://doi.org/10.22159/ijap.2025v17i2.53156.